Clinical course, social functioning, quality of life and medication toler-ability during three years of treatment: Final results from the schizophrenia outpatient health outcomes (SOHO)study

被引：0
|
作者：
Jones, PB
Novick, D
Brown, J
Suarez, D
Kennedy, L
Haro, JM
机构：
[1] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England
[2] Eli Lilly & Co, Windlesham GU20 6PH, Surrey, England
[3] San Joan Deu SSM, Res & Dev Unit, Barcelona, Spain
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [21] Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, Diego
    Maria Haro, Josep
    Perrin, Elena
    Suarez, David
    Texeira, Joao Marques
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (08) : 542 - 550
  • [22] Extrapyramidal symptoms after six months of treatment: Results from the schizophrenia outpatient health outcomes (SOHO) study
    Wright, R
    Haro, JM
    Frewer, P
    Novick, D
    Edgell, ET
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S341 - S342
  • [23] Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Gasquet, I
    Haro, JM
    Novick, D
    Edgell, ET
    Kennedy, L
    Lepine, JP
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (04) : 199 - 205
  • [24] Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
    Novick, D
    Bousono, M
    Suarez, D
    Olivares, JM
    Montejo, AL
    Haro, JM
    Edgell, ET
    Ratcliffe, M
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (06): : 970 - 980
  • [25] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the pan-European SOHO (schizophrenia outpatient health outcomes) study
    Haro, J
    Novick, D
    Belger, M
    Tzivelekis, S
    Murray, D
    Texeira, JM
    Alonso, J
    Bousono, MG
    Gasquet, I
    Kristensen, H
    Jones, PB
    Croudace, T
    Knapp, M
    Lepine, JP
    Mavreas, V
    Naber, D
    Pancheri, P
    Slooff, CJ
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 486 - 486
  • [26] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the Pan-European SOHO (schizophrenia outpatient health outcomes) study
    Novick, D
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 71S - 71S
  • [27] Change in clinical status, social functioning, weight and sexual adverse events over the first 6 months of treatment: pan-european results from the schizophrenia outpatient health outcomes (SOHO) study
    V Mavreas
    D Novick
    S Tzivelekis
    M Ratcliffe
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [28] Predictors of antipsychotic treatment continuation in the outpatient setting: 12-month results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Haro, JM
    Novick, D
    Belger, M
    Tzivelekis, S
    Ratcliffe, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S233 - S234
  • [29] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia. 24-month results from the Pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Haro, JM
    Novick, D
    Belger, M
    Tzivelekis, S
    Bushe, C
    Murray, D
    Texeira, JM
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A10 - A10
  • [30] ADHERENCE WITH ANTIPSYCHOTIC TREATMENT MEDICATION IN OUTPATIENTS WITH SCHIZOPHRENIA: 36-MONTH RESULTS FROM THE SCHIZOPHRENIA OUTPATIENTS HEALTH OUTCOMES (SOHO) STUDY
    Novick, D.
    Suarez, D.
    Haro, J. M.
    Haddad, P. M.
    EUROPEAN PSYCHIATRY, 2009, 24
12345